NCT05738200

Brief Summary

Anterior cruciate ligament (ACL) injuries constitute a significant portion of major knee joint injuries sustained by young, active individuals, and significantly increase risk for long-term disability. Yet the recommended solution to restore joint stability following injury--ACL reconstruction (ACLR)--does not prevent post-traumatic knee osteoarthritis (PTOA). Post-traumatic quadriceps (dys)function is a hallmark characteristic following ACLR, reported to accelerate the onset of PTOA after ACL injury, making the recovery of muscle function a primary concern to clinicians. However, hamstrings muscle function is drastically underrepresented relative to the quadriceps in the context of recovery from ACLR, which impedes the ability to develop targeted treatment approaches. Persistent hamstrings weakness is widely reported in patients who undergo ACLR with a hamstring tendon (HT) autograft, which increases ACL strain, and may contribute to higher graft failure rates in this population. To effectively treat muscular impairments, underlying neuromuscular adaptations known to occur in response to ACLR must be targeted. Eccentric exercise is uniquely suited to enhance neuromuscular function. The Nordic hamstring exercise (NHE) is a specific form of eccentric exercise that is clinically relevant and easy to implement, but has not been explored as an intervention for hamstrings neuromuscular dysfunction in patients who undergo ACLR with HT. To establish an evidence-based treatment model, the investigators will use a single-blind, randomized controlled clinical trial to establish the feasibility and efficacy of a 4-week NHE protocol in patients who undergo ACLR with HT. Separate factorial ANOVAs will be used to assess the effects of group (NHE, control) and time (baseline, 4 weeks) on selected outcomes. Effect sizes will be calculated for within- and between-group comparisons. The investigators expect to observe improvements in hamstrings neuromuscular function following the NHE protocol, and that those improvements will be greater than the control group. Additionally, the investigators expect the protocol to be feasible in terms of intervention adherence and patient retention. This study will identify specific barriers to the implementation of NHE in patients who undergo ACLR with HT, and will provide support for the application of an easy to implement clinical intervention able to address a complex neurophysiological problem.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2018

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
Last Updated

February 21, 2023

Status Verified

February 1, 2023

Enrollment Period

4 years

First QC Date

November 2, 2022

Last Update Submit

February 20, 2023

Conditions

Keywords

Eccentric exerciseHamstrings

Outcome Measures

Primary Outcomes (3)

  • Change in peak eccentric torque

    Hamstrings

    Baseline, 4 weeks

  • Change in peak isometric torque

    Hamstrings

    Baseline, 4 weeks

  • Change in peak isokinetic torque

    Hamstrings

    Baseline, 4 weeks

Secondary Outcomes (8)

  • Change in rate of torque development

    Baseline, 4 weeks

  • Change in torque coefficient of variation

    Baseline, 4 weeks

  • Change in central activation ratio

    Baseline, 4 weeks

  • Change in single leg hop

    Baseline, 4 weeks

  • Change in active motor threshold

    Baseline, 4 weeks

  • +3 more secondary outcomes

Other Outcomes (13)

  • Change in visual analog scale

    Baseline, 4 weeks

  • Change in Tampa Scale of Kinesiophobia 11-item

    Baseline, 4 weeks

  • Change in ACL Return to Sport after Injury

    Baseline, 4 weeks

  • +10 more other outcomes

Study Arms (2)

Nordic Hamstring Exercise

EXPERIMENTAL

A 4-week (10 session), progressive, Nordic Hamstring Exercise (NHE) protocol will be used for this study.

Other: Nordic Hamstring Exercise

Control

NO INTERVENTION

Patients randomized to the control group will be instructed to avoid any changes to their normal routine (e.g., physical activity level, strength training, etc.). An investigator not involved in data collection will communicate with patients in the control group on a weekly basis to ensure they have not changed their physical activity level and do not have any questions. Patients randomized to the control group will participate in a minimum of 2 study visits at baseline and 4 weeks. These individuals will have the option to open enroll in the intervention group at the completion of their original 4-week study period. Those who choose to enroll in the intervention group at this time will return for 11 additional visits to complete the NHE protocol (visits 3-12) and final assessment (visit 13)

Interventions

A 4-week (10 session), progressive, NHE protocol will be used for this study. Immediately following the completion of study visit 1, patients will be informed about the nature of the NHE protocol. Those available and willing to participate will be randomized to an intervention group (NHE, control). Patients randomized to NHE will receive formal instruction about how to correctly perform the exercise, and will be asked to perform several repetitions to familiarize themselves with the exercise and verify proper technique. At this time, patients will be dismissed from study visit 1, and return visits 2-11 will be scheduled to complete the NHE protocol. Patients will return for a final study visit (12) to record post-intervention measurements within 7 days of completing the NHE protocol. A minimum of 48 hours will be used to separate study visits. To accurately assess patients' ability to perform the NHE, all exercise will be performed on a NordBord Hamstring Testing System.

Nordic Hamstring Exercise

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-35
  • History of primary, unilateral ACL reconstruction (ACLR) with hamstrings tendon autograft

You may not qualify if:

  • Lower extremity orthopedic surgery prior to ACLR
  • Post-surgical complication (e.g. infection, delayed healing)
  • Multiple ligament knee injury
  • Treated articular cartilage lesion
  • Known history of knee osteoarthritis
  • Concussion within 6 months
  • History of neurological disorder
  • Currently taking prescription medication that may alter neural excitability (e.g. stimulants, depressants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Toledo

Toledo, Ohio, 43606, United States

Location

Related Publications (1)

  • Norte GE, Glaviano NR, Sherman DA, Rush JL, Murray AM. Four-week Nordic hamstring exercise intervention for individuals with ACL reconstruction via hamstrings tendon autograft: feasibility of a pilot randomized controlled trial. Pilot Feasibility Stud. 2025 Apr 3;11(1):37. doi: 10.1186/s40814-025-01624-6.

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesMuscle WeaknessNeuromuscular Manifestations

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesMuscular DiseasesMusculoskeletal DiseasesNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Grant Norte, PhD, ATC

    The University of Toledo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2022

First Posted

February 21, 2023

Study Start

July 7, 2018

Primary Completion

July 13, 2022

Study Completion

July 13, 2022

Last Updated

February 21, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations